Hochdorf sells Pharmalys stake to Pharmalys Invest Holding

By Jim Cornall contact

- Last updated on GMT

Hochdorf said it will in future increasingly work with the traditional Swiss brand Bimbosan and the Babina brand.
Hochdorf said it will in future increasingly work with the traditional Swiss brand Bimbosan and the Babina brand.

Related tags: Infant formula

The Board of directors of Switzerland’s Hochdorf Group has sold its 51% majority stake in companies of the Pharmalys Group acquired at the end of 2016 to Pharmalys Invest Holding, controlled by Amir Mechria.

With this move, Hochdorf said is taking a step towards financial recovery and increasing its strategic flexibility. The cooperation between the Hochdorf Group and Pharmalys Group will continue, and Pharmalys Invest Holding remains the largest shareholder of the Hochdorf Group.

At the end of 2016, the Hochdorf Group acquired a 51% stake in three companies of the Pharmalys Group in the hope of accelerating the expansion of its baby care business. Around CHF 245m ($247m) was paid until March 2018. However, Hochdorf said, the business model of Pharmalys gave the Hochdorf executive bodies little transparency in their operational implementation and little influence on relevant parts of the value chain. In addition, the financing of the net current assets of Pharmalys proved to be extremely capital-intensive.

After examining various options, the Pharmalys shares have now been sold. The agreement to sell the 51% shares in Pharmalys Laboratories SA, Pharmalys Africa Sarl and Pharmalys Tunisia SA to Pharmalys Invest Holding was signed on December 6, 2019 for around CHF 100m ($101m). The payment will be made in several instalments until September 2020.

Hochdorf Group said the focus on the high-growth baby care division remains unchanged despite the sale of the Pharmalys shares. Pharmalys intends to continue marketing the Swiss baby food produced by Hochdorf. Hochdorf said it will in future increasingly work with the traditional Swiss brand Bimbosan and the Babina brand.

Hochdorf said that in spite of the sale being an important step towards financial recovery, due to currently low sales in the baby care segment and the technical challenges posed by the new spray tower line in Sulgen, a negative result is still expected for the current fiscal year.

Related news

comments

Post your comment

We will not publish your email address on the website

These comments have not been moderated. You are encouraged to participate with comments that are relevant to our news stories. You should not post comments that are abusive, threatening, defamatory, misleading or invasive of privacy. For the full terms and conditions for commenting see clause 7 of our Terms and Conditions ‘Participating in Online Communities’. These terms may be updated from time to time, so please read them before posting a comment. Any comment that violates these terms may be removed in its entirety as we do not edit comments. If you wish to complain about a comment please use the "REPORT ABUSE" button or contact the editors.